Efficacy News and Research

RSS

LSUHealthNO receives NIH grant to develop novel long-lasting dental filling materials

The National Institute of Dental and Craniofacial Research of the National Institutes of Health has awarded LSU Health New Orleans' School of Dentistry an R01 grant in the amount of $2,465,297 over five years to develop stronger, longer-lasting dental filling materials with antibacterial properties to inhibit recurrent cavities and extend the life of the restoration.

2 May 2017

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

28 Apr 2017

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia who have a specific genetic mutation called FLT3, in combination with chemotherapy.

28 Apr 2017

Study shows safety, efficacy of endoscopic needle knife therapy for intestinal strictures in IBD patients

Cleveland Clinic doctors have published the first study illustrating the safety and efficacy of endoscopic needle knife therapy for intestinal strictures in patients with inflammatory bowel disorder.

28 Apr 2017

New study aims to test safety and efficacy of antiplatelet drug in preventing blood clots

A new clinical study is starting at the German Centre for Cardiovascular Research (DZHK) with an innovative and highly specific blood thinner.

28 Apr 2017

Do brain training apps really work?

There are dozens of brain training apps on the market. Regrettably, very few have any studies showing efficacy. A recent systematic review from experts at five Alzheimer’s research centers looked at 32 brain training programs, and found only seven had any studies to review showing effects in the target population of aging adults.

28 Apr 2017

Stivarga receives expanded FDA approval for treatment of liver cancer

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.

28 Apr 2017

VUMC researcher receives grant to test efficacy of drug for reversing precancerous stomach lesions

Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.

28 Apr 2017

FDA approves first drug for treating rare form of Batten disease

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

27 Apr 2017

Researchers examine morbidity linked to depressive disorders

Ross Baldessarini and an international group of investigators have analyzed the morbidity associated with depressive disorders in the current issue of Psychotherapy and Psychosomatics.

27 Apr 2017

Fecal microbiota transplant may be effective treatment option for ulcerative colitis, research suggests

A single transplant of microbes contained in the stool of a healthy donor is a safe and effective way to increase diversity of good bacteria in the guts of patients with ulcerative colitis, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.

27 Apr 2017

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists have described new results of a blood cancer study as 'outstanding' in tackling previously untreatable forms of chronic lymphocytic leukemia.

27 Apr 2017

Personalized approach to pharmacotherapy may provide advances in treatment of panic disorders

Although drug therapy is the accepted first-line treatment for panic disorders, 17% to 64% of patients do not respond adequately and continue to exhibit one of the most common symptoms of PD, the panic attack.

26 Apr 2017

Early blood test can predict vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.

26 Apr 2017

FDA warns 14 companies for illegal promotion and selling of cancer cure products

The U.S. Food and Drug Administration has issued warning letters today to 14 companies based out of U.S., who are selling more than 65 products illegally making false claims to prevent, diagnose, treat, or cure cancer.

26 Apr 2017

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

The World Health Organization Regional Office for Africa announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated malaria vaccine implementation programme (MVIP) that will make the world’s first malaria vaccine available in selected areas, beginning in 2018.

26 Apr 2017

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

26 Apr 2017

Study shows how gut microbiota may play role in effectiveness of chemotherapy drugs

The bacteria residing in your digestive tract, or your gut microbiota, may play an important role in your ability to respond to chemotherapy drugs in the clinic, according to a new study by scientists at the University of Massachusetts Medical School.

25 Apr 2017

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.

24 Apr 2017

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

Biogen today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorization for SPINRAZA to treat patients with spinal muscular atrophy (SMA).

21 Apr 2017

Efficacy News and Research

LSUHealthNO receives NIH grant to develop novel long-lasting dental filling materials

Takeda announces accelerated approval from FDA for new lung cancer treatment

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Study shows safety, efficacy of endoscopic needle knife therapy for intestinal strictures in IBD patients

New study aims to test safety and efficacy of antiplatelet drug in preventing blood clots

Do brain training apps really work?

Stivarga receives expanded FDA approval for treatment of liver cancer

VUMC researcher receives grant to test efficacy of drug for reversing precancerous stomach lesions

FDA approves first drug for treating rare form of Batten disease

Researchers examine morbidity linked to depressive disorders

Fecal microbiota transplant may be effective treatment option for ulcerative colitis, research suggests

Scientists announce ‘outstanding’ results of new blood cancer study

Personalized approach to pharmacotherapy may provide advances in treatment of panic disorders

Early blood test can predict vaccine immunogenicity

FDA warns 14 companies for illegal promotion and selling of cancer cure products

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study shows how gut microbiota may play role in effectiveness of chemotherapy drugs

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News